Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease
Conclusion
Antifungal prophylaxis with liposomal amphotericin B was well tolerated, but the incidence of invasive fungal infections in patients receiving liposomal amphotericin B was higher than other antifungal agents in this study. The optimal dose and schedule of liposomal amphotericin B for antifungal prophylaxis in this patient population are still not known and considering its broad spectrum activity, prospective trials in comparison to triazoles are warranted.
Source: Journal of Oncology Pharmacy Practice - Category: Cancer & Oncology Authors: Luu Tran, H., Mahmoudjafari, Z., Rockey, M., Henry, D., Grauer, D., Aljitawi, O., Abhyankar, S., Ganguly, S., Lin, T., McGuirk, J. Tags: Original Articles Source Type: research
More News: Abelcet | Cancer & Oncology | Corticosteroid Therapy | Fungal Infections | Stem Cell Therapy | Stem Cells | Study | Transplants